Daisuke Hashimoto

18PUBLICATIONS
49CO-AUTHORS
Intensive careCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNutritional epidemiologyPathology (excl. oral pathology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Oct 06, 2026
Validation of Discharge Criteria and Risk Factors for Readmission After Pancreatoduodenectomy.

|Jul 16, 2026
Neoadjuvant and adjuvant treatment for pancreatic ductal adenocarcinoma in patients over 80 years old based on a nationwide clinical database.

|Jun 25, 2026
Survival Impact of Pathological Residual Patterns for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy.

|Jan 07, 2026
Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed Using a Time-Dependent Cox Regression Model.

Denys Tsybulskyi, Daisuke Hashimoto, Kimitaka Tanaka

|Jul 03, 2025
Clinical role of intraperitoneal chemotherapy in patients with pancreatic ductal adenocarcinoma concomitant with occult peritoneal dissemination: A multicenter retrospective study.

Tomohisa Yamamoto, Toshio Shimokawa, Masamichi Hayashi

|Oct 04, 2023
Central pancreatectomy might be an acceptable surgical procedure for clinical T1 pancreatic body ductal adenocarcinoma: A multicenter retrospective analysis.

Taichi Terai, Manabu Kawai, Yuji Kitahata

Pageof 3

Frequent Collaborators

13 joint publications

Sohei Satoi

4 joint publications

Tomohisa Yamamoto

3 joint publications

Tsutomu Fujii

2 joint publications

Hidetaka Miyazaki